Publication Name	World Journal of Transplantation
Manuscript ID	26712
Country	Belgium

Received	2016-04-23 15:35
Peer-Review Started	2016-04-24 08:19
To Make the First Decision	2016-06-06 10:42
Return for Revision	2016-06-07 10:10
Revised	2016-06-30 23:20
Second Decision	2016-08-11 10:46
Accepted by Journal Editor-in-Chief	2016-08-14 21:38
Accepted by Executive Editor-in-Chief	2016-08-18 11:25
Articles in Press	2016-08-18 11:25
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-09-19 10:32
Publish the Manuscript Online	2016-09-23 15:41

ISSN	2220-3230 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Review
Article Title	Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders
Manuscript Source	Invited Manuscript
All Author List	Julie Morscio and Thomas Tousseyn
Funding Agency and Grant Number
Corresponding Author	Thomas Tousseyn, MD, PhD, Depart­ment of Pathology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. thomas.tousseyn@uzleuven.be
Key Words	Epstein-Barr virus; Post-transplant lympho­proliferative disorder; Immunodeficiency; Diffuse large B-cell lymphoma; Burkitt lymphoma; Plasmablastic lymphoma
Core Tip	At the moment different post-transplant lym-phoproliferative disorders (PTLD) are grouped in broad categories (early, polymorphic, monomorphic and Hodgkin-like PTLD) and the Epstein-Barr virus (EBV) status is not taken into account. However, increasing evidence demonstrates that different malignant PTLD and EBV+ and EBV- lesions are clinically and biologi-cally distinct, stressing the need for subtype-specific manage-ment. We propose that in future studies patients should be stratified according to the histological lymphoma subtype and the EBV status to minimize bias and to simplify the establishment and analysis of clinical trials.
Publish Date	2016-09-23 15:41
Citation	Morscio J, Tousseyn T. Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders. World J Transplant 2016; 6(3): 505-516
URL	http://www.wjgnet.com/2220-3230/full/v6/i3/505.htm
DOI	http://dx.doi.org/10.5500/wjt.v6.i3.505

Full Article (PDF)	WJT-6-505.pdf
Full Article (Word)	WJT-6-505.doc
Manuscript File	26712-Review.docx
Answering Reviewers	26712-Answering reviewers.pdf
Audio Core Tip	26712-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	26712-Conflict-of-interest statement.pdf
Copyright License Agreement	26712-Copyright assignment.pdf
Peer-review Report	26712-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	26712-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	26712-Scientific misconduct check.pdf
Scientific Editor Work List	26712-Scientific editor work list.pdf